Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination

Journal of Infectious Diseases

Volumn 190, Issue 7, 2004, Pages 1286-1294

  Kennedy, Jeffrey S ^a   Frey, Sharon E ^b   Yan, Lihan ^c   Rothman, Alan L ^a   Cruz, John ^a   Newman, Frances K ^b   Orphin, Laura ^a   Belshe, Robert B ^b   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; SMALLPOX VACCINE; VIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNOLOGICAL MEMORY; LYMPHOCYTE PROLIFERATION; NONHUMAN; NORMAL HUMAN; POXVIRUS; PRIORITY JOURNAL; REVACCINATION; SKIN MANIFESTATION; SMALLPOX; T LYMPHOCYTE;

ADULT; ANTIBODIES, VIRAL; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MIDDLE AGED; SMALLPOX VACCINE; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINIA VIRUS;

EID: 4644372386     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/423848     Document Type: Article

References (32)

1. + T cell memory. Immunol Rev 1996; 150: 23-44.
2. + T cells to antigen stimulation in vivo. Nat Immunol 2000; 1:47-53.
3. + T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis and precursor frequency determination. J Virol 1993; 67:5962-7.
4. Wheelock EF. Interferon in dermal crusts of human vaccinia virus vaccinations: possible explanations of the relative benignity of variolation smallpox. Proc Soc Exp Biol Med 1964; 117:650-3.
5. Sarkar JK, Mitra AC, Chakravarty MS. Relationship of clinical severity, antibody level, and previous vaccination state in smallpox. Trans R Soc Trop Med Hyg 1972; 66:789-92.
6. Perrin L-H, Zingernagel RM, Oldstone MBA. Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes. J Exp Med 1977; 146:949-69.
7. + cytotoxic T lymphocytes and interferon-γ- producing T cells after smallpox vaccination. J Infect Dis 2002; 185: 1657-9.
8. + cytotoxic T lymphocytes in humans. J Virol 1993; 67:1538-44.
9. Frey SE, Newman FK, Cruz J, et al. Dose-related effects of smallpox vaccine. N Engl J Med 2002; 346:1275-80.
10. Demkowicz WE, Littaua RA, Wang J, Ennis FA. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J Virol 1996; 70: 2627-31.
11. van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol 1995; 69:4792-6.
12. Marennikova SS. The use of hyperimmune antivaccinial gamma-globulin for the prevention and treatment of smallpox. Bull World Health Organ 1962; 27:325-30.
13. Kempe CH, Berge TO, England B. Hyperimmune vaccinial gamma globulin: source, evaluation and use in prophylaxis and therapy. Pediatrics 1956; 18:177-88.
14. The pathogenesis, pathology and immunology of smallpox and vaccines. In: Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID, eds. Smallpox and its eradication. Geneva: WHO, 1988.
15. Downie AW, McCarthy K. The antibody response in man following infection with viruses of the pox group. III. Antibody response in smallpox. J Hyg (Lond) 1958; 56:479-87.
16. Roberts JA. Histopathogenesis of mousepox. II. Cutaneous infection. Br J Exp Pathol 1962; 43:462-8.
17. Frey SE, Newman FK, Yan L, Belshe RB. Response to smallpox vaccine in persons immunized in the distant past. JAMA 2003; 289:3295-9.
18. + T cell memory determined by clonal burst size. Nature 1994; 369:652-4.
19. + T cells after infection. Nat Immunol 2002; 3:619-26.
20. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002; 346:1300-8.
21. Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003; 9:1131-7.
22. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T cell differentiation: implications for vaccine development. Nat Rev Immunol 2002; 2:251-62.
23. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998; 187:1395-402.
24. + T cells in acute infectious mononucleosis. Nat Med 1996; 2:906-11.
25. + T cells. J Immunol 2002; 168:4184-91.
26. + T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J Infect Dis 2000; 182: 451-8.
27. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
28. + T cells in protection against CMV disease. Blood 2003; 101:2686-92.
29. + lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol 2002; 76:12423-34.
30. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169:1984-92.
31. + T cell responses to newly indentified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J Exp Med 2003; 197: 927-32.
32. + T-cell differentiation in response to viruses. Nat Rev Immunol 2003; 3:931-9.